Bharat Biotech Plans Coronavirus Vaccine

Panacea weighs pros and cons

After two Indian vaccine makers, Serum Institute of India and Cadila Healthcare joined the fight against COVID-19, Bharat Biotech may follow suit. Others like Hilleman have decided against it for the moment while Panacea Biotech is weighing the pros and cons of developing a SARS-CoV-2 vaccine after a sour experience with H1N1.

PS2002_Corona virus vaccine_1630992484_1200.jpg
More Firms In The Fray For The Coronavirus Vaccine • Source: Shutterstock

After two leading Indian vaccine producers announced plans for a SARS-CoV-2 vaccine to tackle COVID-19, a third one Bharat Biotech International Ltd. is drawing up plans to walk down that path.

The modalities, however, are yet to be worked out, "which will probably be done one or two months down the...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Business

More from Scrip